Does Creatine Brain Health Meta-Analysis work?

Updated July 2026

Quick Answer

Creatine Brain Health Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: These changes contribute to increased sarcopenia risk during and after the menopausal transition, with implications for physical function, frailty, and long-term musculoskeletal health [].

Key Takeaways

  • 01These changes contribute to increased sarcopenia risk during and after the menopausal transition, with implications for physical function, frailty, and long-term musculoskeletal health []. [Naddafha Siavash (2026)]
  • 02In addition, creatine may exert direct anabolic or anticatabolic effects on muscle cells and influence bone via increased muscle pulling forces or direct cell signaling in osteoblasts []. [Naddafha Siavash (2026)]
  • 03For example, a 12-week RCT reported that creatine (5 g/day) with RT significantly increased muscle strength and fat-free mass in women aged ~65 years []. [Naddafha Siavash (2026)]
  • 041 2 3 4 5 6 6 Muscle and bone loss accelerate during the postmenopausal years due to aging and estrogen deficiency. [Naddafha Siavash (2026)]
The current Migaku evidence database contains 2 reusable source documents for Creatine Brain Health Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - These changes contribute to increased sarcopenia risk during and after the menopausal transition, with implications for physical function, frailty, and long-term musculoskeletal health []. [Naddafha Siavash (2026); evidence level 1] - In addition, creatine may exert direct anabolic or anticatabolic effects on muscle cells and influence bone via increased muscle pulling forces or direct cell signaling in osteoblasts []. [Naddafha Siavash (2026); evidence level 1] - For example, a 12-week RCT reported that creatine (5 g/day) with RT significantly increased muscle strength and fat-free mass in women aged ~65 years []. [Naddafha Siavash (2026); evidence level 1] - 1 2 3 4 5 6 6 Muscle and bone loss accelerate during the postmenopausal years due to aging and estrogen deficiency. [Naddafha Siavash (2026); evidence level 1] - Commentary: The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. [Citherlet T (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis
  2. Commentary: The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis.